Patent · US Active

Methods of assessing a risk of cancer progression

US8911940B2 · kind B2 · utility

8Cited by
2References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 29, 2010
Grant dateDec 16, 2014
Priority date—
Expiry dateDec 29, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.